PEAK6’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
PEAK6's PACB Position: Q3 2026 in Review
PEAK6 sold out of Pacific Biosciences (PACB) in Q3 2026, closing a stake of 555,552 shares — an estimated $784K sold.
PEAK6 first reported a position in PACB in Q2 2025 and held it in 4 quarters. The position peaked at $1.24M in Q2 2025. 205 funds tracked by Wall St. Rank hold PACB as of Q3 2026.
- PEAK6 reported no remaining Pacific Biosciences position as of Q3 2026 after selling out during the quarter.
- PEAK6 sold 555,552 Pacific Biosciences shares in Q3 2026, an estimated $784K.
- PEAK6 first reported a position in Pacific Biosciences in Q2 2025 and held it in 4 quarters.
- PEAK6's Pacific Biosciences position peaked at $1.24M in Q2 2025.
- 205 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.
Based on PEAK6's 13F filing for Q3 2026, filed 13 Nov 2026.